The Board of the Canadian Association for Interventional Radiology (CAIR) wishes to inform the Speakers of the 2020 Annual Meeting that the event is canceled due to COVID 19.
Arrangements will be made to pay Speakers for expenses incurred so far that cannot be reimbursed. Please forward to Siri Boulom, CAIR Executive Assistant, at cairservice@cairweb.ca your request for reimbursement by March 31st, 2020 at the latest.

At this time, the Board of the Canadian Association for Interventional Radiology (CAIR) wishes to inform CAIR members, allies, corporate partners and sponsors that it does not plan to cancel the 19th edition of the CAIR’s Annual Meeting, to be held May 28-30, 2020, in Montréal, Québec, due to COVID 19.

The CAIR will closely monitor the situation with COVID-19 and will provide periodic updates regarding the Annual Meeting. In addition, the CAIR will introduce measures, to be announced soon, to minimize health risks during the event.

The safety of the attendees is at the forefront of CAIR. Again, we will monitor the COVID-19 situation on an ongoing basis and reassess our position if required.

Thank you for your understanding.

Questions may be addressed to the CAIR Head Office at : cairservice@cairweb.ca.

(article publié en anglais seulement)

The leading-edge work of SJRH interventional radiologists is just one example of how the sub-speciality is coming of age across Canada. Last year the Canadian Association for Interventional Radiology (CAIR) launched the CAIR Initiative, aimed at raising awareness about the benefits of minimally invasive IR treatments, and lifting the hurdles that stand in the way of greater access to treatments.

Dr. Amol Mujoomdar, division head for interventional radiology at London Health Sciences Centre (LHSC) in Ontario, is the current CAIR president. He said the goal of the initiative is to enable change – including the adoption of national standards for IR programs – so that patients have a better understanding of their options and interventional radiology suites will be busier.

“We literally have an IR suite that sits empty because we don’t have the operational funding to staff it,” said Dr. Mujoomdar, noting that due to patient demand, he could “fill it up tomorrow” if the funding was available.

To read more, access the article here, courtesy of the Canadian Healthcare Technology.

(article publié en anglais seulement)

Thanks to research, innovation, and advancements, many of today’s medical procedures can be done in a minimally-invasive way — typically on an outpatient basis — yet be as effective as major surgery.

“Aside from allowing hospitals to function more effectively, minimally-invasive procedures enable patients to resume normal activity, energy, and appetite levels with fewer side effects than one typically gets with big operations,” says Dr. Amol Mujoomdar, Division Head for Interventional Radiology at London Health Sciences Centre and Associate Professor of Radiology and Oncology at Western University.

To read more, access the full article here, courtesy of Media Planet.

(article publié en anglais seulement)

Y90 is a radioactive substance that is used as a medical device to treat cancers such as liver cancer. For liver cancer, Y90 is placed into microscopic beads which are then injected into the tumour in the patient’s liver, where they emit a very high dose of radiation. According to Dr. Amol Mujoomdar of London Health Sciences Centre, the surgeon featured in the video, utilizing Y90 radioembolization “is like going inside the tumour and punching it from the inside out.” With about 2,000 cases of liver cancer diagnosed in Canada each year, Y90 is a less invasive approach to
fighting this type of cancer.

To read more, access the article here, courtesy of Hospital News.